Skip to main content
FinSpry Logo
FinSpry
XTNT logo
XTNT
(NYSEAMERICAN)
Xtant Medical Holdings, Inc.
$0.49-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Xtant Medical Holdings (XTNT) Stock Price & Financial Analysis

Xtant Medical Holdings Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$0.49 - $0.53
52-Week High$0.95
52-Week Low$0.34
Open$0.53
Volume191.91K
Average Volume (3M)191.91K
Market Cap74.00M
Shares Outstanding150.38M
P/E Ratio (TTM)45.70
Price to Sales (P/S)0.60
Price to Book (P/B)1.59
EV/EBITDA9.02
Revenue (TTM)133.08M
Net Income (TTM)1.75M
Free Cash Flow (TTM)5.17M
EPS (TTM)$0.01
Profit Margin1.32%
Operating Margin4.77%
Return on Equity (ROE)3.48%
Debt to Equity0.57
50-Day MA$0.60
200-Day MA$0.66
52-Week Change13.19%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Xtant Medical Holdings

What is the current stock price for XTNT?

As of the latest trading session, XTNT stock trades at $0.49. The 52-week range is $0.34–$0.95, with a day range of $0.49–$0.53.

What is the P/E ratio for XTNT?

Xtant Medical Holdings's trailing P/E ratio is 45.7, meaning investors pay $45.7 for every $1 of annual earnings. Xtant Medical Holdings operates in the Healthcare sector.

Does XTNT pay dividends?

Xtant Medical Holdings does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for XTNT?

Based on 1 analyst, the consensus for XTNT is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of XTNT?

Xtant Medical Holdings's market capitalization is $74.0M, classifying it as a micro-cap company. Xtant Medical Holdings operates in the Healthcare sector within the Medical Devices industry.